ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization

por Lyon, Anastasia, Tripathi, Rakshamani, Meeks, Christina, He, Daheng, Wu, Yuanyuan, Liu, Jinpeng, Wang, Chi, Chen, Jing, Zhu, Haining, Mukherjee, Sujata, Ganguly, Saptadwipa, Plattner, Rina
Publicado 2023

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling

por Tripathi, Rakshamani, Liu, Zulong, Jain, Aditi, Lyon, Anastasia, Meeks, Christina, Richards, Dana, Liu, Jinpeng, He, Daheng, Wang, Chi, Nespi, Marika, Rymar, Andrey, Wang, Peng, Wilson, Melissa, Plattner, Rina
Publicado 2020